Amanta Healthcare Ltd (AMANTA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 10039743,
    "name": "Amanta Healthcar",
    "stock_name": "Amanta Healthcar",
    "full_name": "Amanta Healthcare Ltd",
    "name_url": "stocks-analysis/amanta-healthcar",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "146.00",
    "chg": -2.25,
    "chgp": "-1.52%",
    "dir": -1,
    "prev_price": "148.25",
    "mcapval": "583.00 Cr",
    "mcap": "",
    "scripcode": 544502,
    "symbol": "AMANTA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE084K01015",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "60.14 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/amanta-healthcar-10039743-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Amanta Healthcare Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-amanta-healthcare-ltd-latest-results-good-or-bad-4001527",
        "imagepath": "",
        "date": "2026-05-20 19:26:00",
        "description": "Amanta Healthcare Ltd's latest financial results for Q4 FY26 reflect a complex operational landscape. The company reported net sales of ₹76.99 crores, marking a sequential increase of 3.36% from the previous quarter and a year-on-year growth of 6.84%. This indicates some positive momentum in revenue generation, potentially suggesting improved market penetration or product portfolio expansion.\n\nHowever, the operational efficiency metrics reveal challenges. The net profit for the quarter rose to ₹5.53 crores, a 19.44% increase from Q3 FY26, driven by lower interest costs and a slight uptick in other income. Despite this, the net profit remains below the previous year's figure, highlighting ongoing profitability concerns. The operating margin contracted to 19.42%, down from 20.62% in the prior quarter, indicating significant cost pressures or pricing challenges that may affect the company's ability to maintain..."
      },
      {
        "title": "Amanta Healthcare Ltd Reports Flat Quarterly Performance Amid Margin Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/amanta-healthcare-ltd-reports-flat-quarterly-performance-amid-margin-pressure-4000008",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AmantaHealthcar_fintrenddot_4000008.png",
        "date": "2026-05-20 08:00:24",
        "description": "Amanta Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a flat financial performance for the quarter ended March 2026, marking a notable shift from its previously positive growth trajectory. Despite achieving record net sales and a strong operating profit to interest ratio, the company’s operating profit margin contracted significantly, prompting a downgrade in its Mojo Grade from Hold to Sell."
      },
      {
        "title": "When is the next results date for Amanta Healthcare Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-amanta-healthcare-ltd-3988254",
        "imagepath": "",
        "date": "2026-05-12 23:18:01",
        "description": "The next results date for Amanta Healthcare Ltd is scheduled for 19 May 2026...."
      },
      {
        "title": "Amanta Healthcare Ltd Falls 1.85%: 3 Key Factors Driving the Weekly Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/amanta-healthcare-ltd-falls-185-3-key-factors-driving-the-weekly-decline-3982587",
        "imagepath": "",
        "date": "2026-05-09 09:01:57",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>May 4:</strong> Technical momentum shifts amid mixed market signals</p>\n                    <p><strong>May 5:</strong> Technical momentum shifts to mildly bullish with strong price gains</p>\n                    <p><strong>May 6:</strong> MarketsMOJO upgrades rating to Hold following financial improvements</p>\n                    <p><strong>May 8:</strong> Week closes at Rs.137.70, down 1.85%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.140.30</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"sta..."
      },
      {
        "title": "Amanta Healthcare Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/amanta-healthcare-ltd-is-rated-hold-3964235",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AmantaHealthcar_mojoScore_3964235.png",
        "date": "2026-04-27 10:10:52",
        "description": "Amanta Healthcare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 15 April 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 27 April 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Amanta Healthcare Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/amanta-healthcare-ltd-downgraded-to-sell-amid-mixed-financial-and-technical-signals-3936643",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AmantaHealthcar_mojoScore_3936643.png",
        "date": "2026-04-08 08:31:35",
        "description": "Amanta Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 7 April 2026. This change reflects a nuanced assessment across four critical parameters: quality, valuation, financial trend, and technicals. Despite some encouraging quarterly financial results, the overall outlook has been tempered by weak long-term fundamentals and a shift in technical momentum."
      },
      {
        "title": "Amanta Healthcare Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/amanta-healthcare-ltd-is-rated-sell-3928458",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AmantaHealthcar_mojoScore_3928458.png",
        "date": "2026-04-01 10:10:03",
        "description": "Amanta Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 April 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Amanta Healthcare Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/amanta-healthcare-ltd-is-rated-sell-3905006",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AmantaHealthcar_mojoScore_3905006.png",
        "date": "2026-03-21 10:10:03",
        "description": "Amanta Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 December 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 21 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 15,
    "sid": "10039743",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/amanta-healthcare-10039743"
  },
  "announcements": [
    {
      "caption": "Intimation For Commissioning Of Solar Power Plant For Captive Consumption",
      "datetime": "30-May-2026",
      "details": "Intimation for commissioning of solar power plant for captive consumption",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "30-May-2026",
      "details": "Annual Secretarial Compliance Report for the Financial Year ended on March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Statement Of Deviation Or Variation In Utilization Of Funds If Any.",
      "datetime": "29-May-2026",
      "details": "statement of deviation or variation of funds if any",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Are Amanta Healthcare Ltd latest results good or bad?

2026-05-20 19:26:00

Amanta Healthcare Ltd's latest financial results for Q4 FY26 reflect a complex operational landscape. The company reported net sales of ₹76.99 crores, marking a sequential increase of 3.36% from the previous quarter and a year-on-year growth of 6.84%. This indicates some positive momentum in revenue generation, potentially suggesting improved market penetration or product portfolio expansion. However, the operational efficiency metrics reveal challenges. The net profit for the quarter rose to ₹5.53 crores, a 19.44% increase from Q3 FY26, driven by lower interest costs and a slight uptick in other income. Despite this, the net profit remains below the previous year's figure, highlighting ongoing profitability concerns. The operating margin contracted to 19.42%, down from 20.62% in the prior quarter, indicating significant cost pressures or pricing challenges that may affect the company's ability to maintain...

Amanta Healthcare Ltd Reports Flat Quarterly Performance Amid Margin Pressure

2026-05-20 08:00:24

Amanta Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a flat financial performance for the quarter ended March 2026, marking a notable shift from its previously positive growth trajectory. Despite achieving record net sales and a strong operating profit to interest ratio, the company’s operating profit margin contracted significantly, prompting a downgrade in its Mojo Grade from Hold to Sell.

When is the next results date for Amanta Healthcare Ltd?

2026-05-12 23:18:01

The next results date for Amanta Healthcare Ltd is scheduled for 19 May 2026....

Amanta Healthcare Ltd Falls 1.85%: 3 Key Factors Driving the Weekly Decline

2026-05-09 09:01:57

Key Events This Week May 4: Technical momentum shifts amid mixed market signals May 5: Technical momentum shifts to mildly bullish with strong price gains May 6: MarketsMOJO upgrades rating to Hold following financial improvements May 8: Week closes at Rs.137.70, down 1.85% Week OpenRs.140.30 Week Close<div class="sta...

Amanta Healthcare Ltd is Rated Hold

2026-04-27 10:10:52

Amanta Healthcare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 15 April 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 27 April 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.

Amanta Healthcare Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals

2026-04-08 08:31:35

Amanta Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 7 April 2026. This change reflects a nuanced assessment across four critical parameters: quality, valuation, financial trend, and technicals. Despite some encouraging quarterly financial results, the overall outlook has been tempered by weak long-term fundamentals and a shift in technical momentum.

Amanta Healthcare Ltd is Rated Sell

2026-04-01 10:10:03

Amanta Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 April 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.

Amanta Healthcare Ltd is Rated Sell

2026-03-21 10:10:03

Amanta Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 December 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 21 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

View All News